Cara Therapeutics (CARA) option implied volatility elevated into ongoing Phase III trials

May 29, 2019 6:07 AM

Cara Therapeutics (NASDAQ: CARA) June call ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found